Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015674 (
chronic fatigue syndrome
)
2,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The overlap of symptoms in
chronic fatigue syndrome
(
CFS
) and psychiatric disorders such as depression can complicate diagnosis. Patients often complain that they are wrongly given a psychiatric label. We compared psychiatric diagnoses made by general practitioners and hospital doctors with diagnoses established according to research diagnostic criteria. 68
CFS
patients referred to a hospital fatigue clinic were assessed, and psychiatric diagnoses were established by use of a standardized interview schedule designed to provide current and lifetime diagnoses. These were compared with psychiatric diagnoses previously given to patients. Of the 31 patients who had previously received a psychiatric diagnosis 21 (68%) had been misdiagnosed: in most cases there was no evidence of any past or current
psychiatric disorder
. Of the 37 patients who had not previously received a psychiatric diagnosis 13 (35%) had a treatable
psychiatric disorder
in addition to
CFS
. These findings highlight the difficulties of routine clinical evaluation of
psychiatric disorder
in
CFS
patients. We advise doctors to focus on subtle features that discriminate between disorders and to use a brief screening instrument such as the Hospital Anxiety and Depression Scale.
...
PMID:Diagnosis of psychiatric disorder in clinical evaluation of chronic fatigue syndrome. 1091 26
The prevalence of chronic widespread pain in the general population in Israel was comparable with reports from the USA, UK, and Canada. Comorbidity with fibromyalgia (FM) resulted in somatic hyperalgesia in patients with irritable bowel syndrome. One sixth of the subjects with chronic widespread pain in the general population were also found to have a
mental disorder
. Mechanisms involved in referred pain, temporal summation, muscle hyperalgesia, and muscle pain at rest were attenuated by the N-methyl-D-aspartate (NMDA) antagonist, ketamine, in FM patients. Delayed corticotropin release, after interleukin-6 administration, in FM was shown to be consistent with a defect in hypothalamic corticotropin-releasing hormone neural function. The basal autonomic state of FM patients was characterized by increased sympathetic and decreased parasympathetic systems tones. The severity of functional impairment as assessed by the Medical Outcome Survey Short Form (SF-36) discriminated between patients with widespread pain alone and FM patients.
Chronic fatigue syndrome
(
CFS
) occurred in about 0.42% of a random community-based sample of 28,673 adults in Chicago, Illinois. A significant clinical overlap between
CFS
and FM was reported. Cytokine dysregulation was not found to be a singular or dominant factor in the pathogenesis of
CFS
. A favorable outcome of
CFS
in children was reported; two thirds recovered and resumed normal activities. No major therapeutic trials in FM and
CFS
were reported over the past year.
...
PMID:Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. 1122 36
Chronic fatigue syndrome
(
CFS
) is a common illness of unknown etiology and pathogenesis characterized by severe disabling fatigue and a variety of musculoskeletal, neurocognitive, mood symptoms and sleep disorders lasting at least six months. A significant proportion of patients fulfilling operative criteria for a diagnosis of
CFS
will also meet criteria for a
psychiatric disorder
such as depression, somatization or anxiety disorders. Premorbid lifestyle may play a predisposing, and/or perpetuating role in
CFS
. Some patients improve with time but most remain functionally impaired for several years. A variety of interventions have been used in the treatment and management of
CFS
. Interventions which have shown promising results include cognitive behavioural therapy and graded exercise therapy. Antidepressants can be useful particularly in the case of comorbid affective disorders. Development of good therapeutic doctor-patient alliance with empathic care is central to the effective management of
CFS
. In this article we overview the nature and definition of
CFS
. The prevalence, the prognosis and the psychopathological issues are presented. The management of this controversial syndrome is discussed.
...
PMID:[Chronic fatigue syndrome: psychiatric perspectives]. 1242 51
Differences between patients with postinfectious
chronic fatigue syndrome
(
CFS
, n = 16) and noninfectious
CFS
(n = 20) were clarified. The noninfectious
CFS
group had problems in family and developmental history, and had chronic stresses. Members of the postinfectious
CFS
group were social extroverts while those in the noninfectious
CFS
group was neurotic and introspective. Natural killer cell activity was suppressed in both groups. These findings suggest that the postinfectious
CFS
group and the noninfectious
CFS
group differed in their pathogenesis until the onset of
CFS
. The latter group should be considered as a variant of
psychiatric disorder
and treated accordingly.
...
PMID:Psychosocial characteristics and immunological functions in patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. 1244 62
Individuals with
chronic fatigue syndrome
(
CFS
) face chronic physical debilitation, reduced neuropsychological functioning, and changes in emotional well-being that significantly detract from quality of life. The role of psychiatric disturbance in reducing quality of life in
CFS
remains unclear. In the current investigation, the role of psychiatric status in reducing health-related quality of life in
CFS
was examined. Four subject groups were compared on measures of functional well-being, mood, and neuropsychological status: individuals with
CFS
and no history of
psychiatric illness
, individuals who had current symptoms of
psychiatric illness
that began after their
CFS
diagnosis, individuals who had current symptoms of
psychiatric illness
that began before their
CFS
diagnosis, and a healthy sedentary control group. Overall, it was found that individuals with
CFS
suffer from profound physical impairment. Concurrent
psychiatric illness
, however, did not adversely affect physical functional capacity. Physical functional capacity was not worse in individuals with a concurrent
psychiatric illness
. As expected, concurrent
psychiatric illness
was found to reduce emotional well-being. Moreover, individuals with a
psychiatric illness
that predated the onset of
CFS
suffered the greatest emotional distress. Thus, an individual's psychiatric history should be considered when attempting to understand the factors maintaining disability in
CFS
.
...
PMID:Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS): relationship to psychiatric disorder. 1281 52
Psychiatric disorders
have been associated with poor outcome in individuals with
chronic fatigue syndrome
(
CFS
). This study examines the impact of psychiatric disorders on outcome of cognitive-behavioural therapy (CBT). Psychiatric diagnoses were assessed with a structured psychiatric interview in a CBT trial of 270 people with
CFS
. Lifetime and current psychiatric disorders were found in 50 and 32% respectively. No significant differences in fatigue severity and functional impairment following treatment were found between participants with and without psychiatric diagnoses.
...
PMID:Effect of psychiatric disorders on outcome of cognitive-behavioural therapy for chronic fatigue syndrome. 1605 33
Prior studies on brain blood flow in
chronic fatigue syndrome
(
CFS
) did not find consistent results. This may be because they used single-photon emission computed tomography to measure brain blood flow, which could not measure absolute blood flow. Therefore, the aim of this study was to test the hypothesis that patients with
CFS
have reduced absolute cerebral blood flow. Xenon-computed tomography blood flow studies were done on 25
CFS
patients and seven healthy controls. Analyses were done after stratifying the
CFS
patients based on the presence or absence of a current
psychiatric disorder
. Flow was diminished in both groups as follows: patients with no current psychiatric disorders had reduced cortical blood flow in the distribution of both right and left middle cerebral arteries (P<0.05 for both) while those with current psychiatric disorders had reduced blood flow only in the left middle cerebral artery territory (P<0.05). These data indicate that patients with
CFS
have reduced absolute cortical blood flow in rather broad areas when compared with data from healthy controls and that those devoid of psychopathology had the most reductions in cortical flow. These data support, in part, our earlier findings that patients devoid of psychopathology are the group most at risk of having some of the symptoms of
CFS
due to brain dysfunction.
...
PMID:Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. 1649 97
Chronic fatigue occurring in previously healthy children and adolescents is a vexing problem encountered by pediatric practitioners and the impact of fatigue in youngsters should not be underestimated. In its severe form, it is often associated with mood disorders. Findings in children and adolescent cases suggest that severe unexplained fatigue might precede the development of fatigue-related illness, such as childhood
chronic fatigue syndrome
(CCFS). This is a disabling condition characterized by severe disabling fatigue and a combination of symptoms, the prominent features being self-reported impairments in concentration and short-term memory, sleep disturbances and autonomic symptoms that cannot be explained by medical or
psychiatric illness
. We have encountered such patients with these complaints; their major symptoms include: general fatigue, fever, headache (not migraine), and memory disturbance. From our clinical experience, we have inferred that patients with CCFS might experience changes in brain function levels, which induce an autonomic imbalance and engender symptoms such as general fatigue, higher-order level cognitive dysfunction, and memory disturbance.
...
PMID:[School phobia and childhood chronic fatigue syndrome (CCFS)]. 1756 7
This article reviews several areas of new and interesting development in the fields of psychosomatics and psychotherapy published in the literature during 2006. These areas are: (1) cardiovascular illness and its interplay with depression; (2) risks and predisposing factors in the areas of
mental illness
and physical illness; (3) new developments in
chronic fatigue syndrome
, and (4) new or newly explored/modified (psycho)therapies, especially cognitive-behavioral therapy. In addition, an important area of conflict of interest in psychiatry in particular and in biomedical science in general is discussed, as this issue has reached prominence in the biomedical literature.
...
PMID:Reflections on relevance: the fields of psychosomatics and psychotherapy in 2006. 1757 Sep 58
Chronic fatigue syndrome
(
CFS
), a complex illness characterized by fatigue, impaired concentration, and musculoskeletal pain, is often misdiagnosed as a
psychiatric illness
due to the overlap of its symptoms with mood and anxiety disorders. Using proton magnetic resonance spectroscopic imaging ((1)H MRSI), we previously measured levels of the major brain metabolites in
CFS
, in generalized anxiety disorder (GAD), and in healthy control subjects, and found significantly higher levels of ventricular cerebrospinal fluid (CSF) lactate in
CFS
compared to the other two groups. In the present study, we sought to assess the specificity of this observation for
CFS
by comparing ventricular lactate levels in a new cohort of 17
CFS
subjects with those in 19 healthy volunteers and in 21 subjects with major depressive disorder (MDD), which, like GAD, is a neuropsychiatric disorder that has significant symptom overlap with
CFS
. Ventricular CSF lactate was significantly elevated in
CFS
compared to healthy volunteers, replicating the major result of our previous study. Ventricular lactate measures in MDD did not differ from those in either
CFS
or healthy volunteers. We found a significant correlation between ventricular CSF lactate and severity of mental fatigue that was specific to the
CFS
group. In an exploratory analysis, we did not find evidence for altered levels of the amino acid neurotransmitters, gamma-aminobutyric acid (GABA) and glutamate + glutamine ('Glx'), in
CFS
compared to MDD or healthy controls. Future (1)H MRS studies with larger sample sizes and well-characterized populations will be necessary to further clarify the sensitivity and specificity of neurometabolic abnormalities in
CFS
and MDD.
...
PMID:Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. 2066 76
<< Previous
1
2
3
4
5
6
7
Next >>